Skip to main content
. 2020 Oct;12(10):5571–5579. doi: 10.21037/jtd-20-1898

Table 4. Systematic review of four original articles on TPO.

References Nienhuis et al. [1990] (17) Leske et al. [2001] (6) Zhu et al. [2014] (7) Luo et al. [2019] (18)
Study population/country 15/America 41/(France, multicentre) 22/China 73/China
Age (mean, year)/male (%) 63.5/47 63/46 47.5/50 52.8/59
Symptoms Cough (66%), haemoptysis (60%), dyspnoea (53%) Chronic cough (54%), haemoptysis (20%) Chronic cough (64%), haemoptysis (45%) Cough (47%), haemoptysis (23%), expectoration (21%)
PFT Normal (14%), obstructive defects (71%) Normal (43%), obstructive defects (39%), restrictive defects (18%) N/A N/A
Chest CT scan Intraluminal calcification (33%), normal (42%) Submucosal nodules (74%), submucosal calcification (61%), tracheal stenosis (10%) Beaded or scalloped (77%), calcification (64%), tracheal stenosis (27%) Submucosal calcification (87.5%), normal (12.5)
Bronchoscopy Both trachea and bronchi (40%) Airway obstruction (34%), whole trachea (71%), upper trachea (76%) Whole trachea (77%), upper trachea (9%), lower trachea (14%), Rt. main bronchus (73%), Lt. main bronchus (68%) Tracheal stenosis (12%)
Histology Normal (91%), squamous metaplasia (9%) Squamous metaplasia (48%), cartilage (38%), bone (58%) Cartilaginous (61%), bony (78%), squamous metaplasia (78%) Squamous metaplasia (7%), ossification (54%), cartilage (14%)
Treatment Cryotherapy (6.7%), laser therapy (6.7%) Inhaled corticosteroids (20%), antibiotics (17%), laser therapy (2.4%) Inhaled corticosteroids (36%) Bronchoscopic treatment (4%)
Clinical outcome Death (0%) Asymptomatic (24%), chronic or recurrent symptoms (76%), death (2.4%) Remission of symptoms (86%), death (4.5%) Death (6.8%)

TPO, tracheobronchopathia osteochondroplastica; PFT, pulmonary function test; CT, computed tomography.